| 產(chǎn)品編號 | bs-16961R-Gold |
| 英文名稱 | Rabbit Anti-NS5ATP9/Gold Conjugated antibody |
| 中文名稱 | 膠體金標(biāo)記的丙型肝炎病毒NS5A激活蛋白9抗體 |
| 別 名 | KIAA0101 HCV NS5A transactivated protein 9; HCV NS5A-transactivated protein 9; Hepatitis C virus NS5A transactivated protein 9; Hepatitis C virus NS5A-transactivated protein 9; KIAA0101; L5; NS5 ATP9; NS5ATP9; OEATC 1; OEATC; OEATC-1; OEATC1; Overexpressed in anaplastic thyroid carcinoma 1; p15(PAF); p15PAF; PAF; PAF_HUMAN; PCNA associated factor; PCNA-associated factor. |
| 規(guī)格價格 | 100ul/2980元 購買 大包裝/詢價 |
| 說 明 書 | 100ul（10nm 15nm 35nm） |
| 研究領(lǐng)域 | 細(xì)胞生物 細(xì)胞凋亡 細(xì)菌及病毒 新陳代謝 |
| 抗體來源 | Rabbit |
| 克隆類型 | Polyclonal |
| 交叉反應(yīng) | (predicted: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Sheep, ) |
| 產(chǎn)品應(yīng)用 | IEM=1:20-200 ICA=1:20-200 ChIP=1:20-200
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 分 子 量 | 12kDa |
| 性 狀 | Lyophilized or Liquid |
| 濃 度 | 0.4mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human NS5ATP9 |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 儲 存 液 | 0.02M TBS(pH8.2) with 1% BSA, 0.03% Proclin300. |
| 保存條件 | Store at 2-8 oC for 3-6 months. Avoid repeated freeze/thaw cycles. |
| 產(chǎn)品介紹 |
Function: May be involved in protection of cells from UV-induced cell death. Subunit: Interacts (when monoubiquitinated at Lys-15 and Lys-24)with PCNA. Interacts with isoform 2/p33ING1b of ING1. Interacts with BRCA1. Subcellular Location: Nucleus. Cytoplasm, perinuclear region. Tissue Specificity: Expressed predominantly in liver, pancreas and placenta. Not detected in heart or brain. Highly expressed in a number of tumors, especially esophageal tumors, in anaplastic thyroid carcinomas and in non-small-cell lung cancer lines. Database links: Entrez Gene: 9768 Human Omim: 610696 Human SwissProt: Q15004 Human Unigene: 81892 Human Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
